Liquid biopsy - a review

Introduction and objective: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Early detection is crucial for better outcomes. Traditional diagnostic methods, such as imaging and biopsies, often fail to detect HCC in early stages. Liquid biopsy, based on circulati...

Full description

Saved in:
Bibliographic Details
Main Authors: WERONIKA RUTKOWSKA-KAWALEC, Karolina Michalczuk, Dariusz Fabian, Marek Kurowski, Elżbieta Leszczyńska-Knaga, Natalia Jakubczyk, Paweł Moczydłowski, Monika Ryglewicz, Anna Gliwa, Karolina Kuczapska
Format: Article
Language:English
Published: Kazimierz Wielki University 2025-01-01
Series:Journal of Education, Health and Sport
Subjects:
Online Access:https://apcz.umk.pl/JEHS/article/view/56584
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556501611675648
author WERONIKA RUTKOWSKA-KAWALEC
Karolina Michalczuk
Dariusz Fabian
Marek Kurowski
Elżbieta Leszczyńska-Knaga
Natalia Jakubczyk
Paweł Moczydłowski
Monika Ryglewicz
Anna Gliwa
Karolina Kuczapska
author_facet WERONIKA RUTKOWSKA-KAWALEC
Karolina Michalczuk
Dariusz Fabian
Marek Kurowski
Elżbieta Leszczyńska-Knaga
Natalia Jakubczyk
Paweł Moczydłowski
Monika Ryglewicz
Anna Gliwa
Karolina Kuczapska
author_sort WERONIKA RUTKOWSKA-KAWALEC
collection DOAJ
description Introduction and objective: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Early detection is crucial for better outcomes. Traditional diagnostic methods, such as imaging and biopsies, often fail to detect HCC in early stages. Liquid biopsy, based on circulating free DNA (cfDNA) analysis, offers a promising, non-invasive approach, allowing frequent testing, addressing tumor heterogeneity, and reducing costs. Review methods: This article's databases were accessed through the WHO website, PubMed, and Google Scholar. A brief description of the state of knowledge: Early detection of HCC significantly improves survival. Biomarkers from cfDNA, including DNA fragment patterns, methylation markers (e.g., USP44), 5-hydroxymethylcytosine (5hmC), and digital PCR analysis, have shown potential in early-stage detection. Advanced cfDNA fragmentomics identifies tumor-specific DNA fragmentation patterns. Techniques like DELFI demonstrate high sensitivity (94%) and specificity (98%). Machine learning enhances cfDNA analysis by integrating multiple markers, improving accuracy in distinguishing cancerous from precancerous states. Combining methylation analysis with machine learning further addresses challenges of tumor heterogeneity. Summary: Studies highlight the high sensitivity and specificity of cfDNA biomarkers for HCC diagnosis, especially in high-risk groups like individuals with cirrhosis. Integrating technologies like 5hmC analysis and machine learning enables early diagnosis and treatment monitoring. These advancements represent a transformative step in cancer diagnostics, offering effective tools to improve patient outcomes.
format Article
id doaj-art-6f1ae283199943e08bb578b987fd0829
institution Kabale University
issn 2391-8306
language English
publishDate 2025-01-01
publisher Kazimierz Wielki University
record_format Article
series Journal of Education, Health and Sport
spelling doaj-art-6f1ae283199943e08bb578b987fd08292025-01-07T08:16:39ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062025-01-017710.12775/JEHS.2025.77.56584Liquid biopsy - a reviewWERONIKA RUTKOWSKA-KAWALEC0https://orcid.org/0009-0002-4283-6458Karolina Michalczuk1https://orcid.org/0000-0002-4427-9133Dariusz Fabian2https://orcid.org/0009-0006-7241-7245Marek Kurowski3https://orcid.org/0009-0008-2831-3312Elżbieta Leszczyńska-Knaga4https://orcid.org/0009-0007-5584-8614Natalia Jakubczyk5https://orcid.org/0009-0008-3190-4658Paweł Moczydłowski6https://orcid.org/0009-0007-1555-2958Monika Ryglewicz7https://orcid.org/0009-0006-1063-2265Anna Gliwa8https://orcid.org/0009-0006-0251-0591Karolina Kuczapskahttps://orcid.org/0000-0002-5921-1094Tytus Chałubiński Regional Hospital in ZakopaneV Wojskowy Szpital Kliniczny z Polikliniką w KrakowieSpecjalistyczny Szpital Wojewódzki w CiechanowieSzpital MSWiA w ŁodziWojewódzki Szpital Specjalistyczny MEGREZ w TychachSzpital MSWiA w ŁodziSzpital Miejski Specjalistyczny im. G. Narutowicza w KrakowieSzpital Bielański WarszawaUniwersytecki Szpital Kliniczny we Wrocławiu Introduction and objective: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Early detection is crucial for better outcomes. Traditional diagnostic methods, such as imaging and biopsies, often fail to detect HCC in early stages. Liquid biopsy, based on circulating free DNA (cfDNA) analysis, offers a promising, non-invasive approach, allowing frequent testing, addressing tumor heterogeneity, and reducing costs. Review methods: This article's databases were accessed through the WHO website, PubMed, and Google Scholar. A brief description of the state of knowledge: Early detection of HCC significantly improves survival. Biomarkers from cfDNA, including DNA fragment patterns, methylation markers (e.g., USP44), 5-hydroxymethylcytosine (5hmC), and digital PCR analysis, have shown potential in early-stage detection. Advanced cfDNA fragmentomics identifies tumor-specific DNA fragmentation patterns. Techniques like DELFI demonstrate high sensitivity (94%) and specificity (98%). Machine learning enhances cfDNA analysis by integrating multiple markers, improving accuracy in distinguishing cancerous from precancerous states. Combining methylation analysis with machine learning further addresses challenges of tumor heterogeneity. Summary: Studies highlight the high sensitivity and specificity of cfDNA biomarkers for HCC diagnosis, especially in high-risk groups like individuals with cirrhosis. Integrating technologies like 5hmC analysis and machine learning enables early diagnosis and treatment monitoring. These advancements represent a transformative step in cancer diagnostics, offering effective tools to improve patient outcomes. https://apcz.umk.pl/JEHS/article/view/56584Hepatocellular carcinomaearly-stage HCCliquid biopsydiagnosis
spellingShingle WERONIKA RUTKOWSKA-KAWALEC
Karolina Michalczuk
Dariusz Fabian
Marek Kurowski
Elżbieta Leszczyńska-Knaga
Natalia Jakubczyk
Paweł Moczydłowski
Monika Ryglewicz
Anna Gliwa
Karolina Kuczapska
Liquid biopsy - a review
Journal of Education, Health and Sport
Hepatocellular carcinoma
early-stage HCC
liquid biopsy
diagnosis
title Liquid biopsy - a review
title_full Liquid biopsy - a review
title_fullStr Liquid biopsy - a review
title_full_unstemmed Liquid biopsy - a review
title_short Liquid biopsy - a review
title_sort liquid biopsy a review
topic Hepatocellular carcinoma
early-stage HCC
liquid biopsy
diagnosis
url https://apcz.umk.pl/JEHS/article/view/56584
work_keys_str_mv AT weronikarutkowskakawalec liquidbiopsyareview
AT karolinamichalczuk liquidbiopsyareview
AT dariuszfabian liquidbiopsyareview
AT marekkurowski liquidbiopsyareview
AT elzbietaleszczynskaknaga liquidbiopsyareview
AT nataliajakubczyk liquidbiopsyareview
AT pawełmoczydłowski liquidbiopsyareview
AT monikaryglewicz liquidbiopsyareview
AT annagliwa liquidbiopsyareview
AT karolinakuczapska liquidbiopsyareview